NCT03158623View on ClinicalTrials.gov

Wound Additives in Primary Total Joint Athroplasty

PHASE3CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

April 1, 2016

Primary Completion Date

December 6, 2016

Study Completion Date

December 20, 2016

Conditions
Arthroplasty, Replacement
Interventions
BIOLOGICAL

Platelet Rich Plasma

BIOLOGICAL

Cellerate

All Listed Sponsors
lead

Salt Lake Orthopedic Clinic

OTHER

NCT03158623 - Wound Additives in Primary Total Joint Athroplasty | Biotech Hunter | Biotech Hunter